The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
AIMS To evaluate the effect of dulaglutide on body composition in type 2 diabetes mellitus (T2DM) patients undergoing hemodialysis (HD). METHODS Twenty-one T2DM patients on HD, who had been treated with insulin and newly added teneligliptin (N = 10) or dulaglutide (N = 11), were enrolled. Body composition changes, such as fat mass (FM) and skeletal muscle mass (SMM), glycated albumin (GA), and insulin doses were compared before and after six months of treatment with teneligliptin or dulaglutide. RESULTS The percentage changes of GA and insulin doses were comparable between the teneliglipin and dulaglutide groups. Conversely, although FM and SMM did not change in the teneligliptin group (from 15.7 kg to 14.1 kg, P = 0.63 and 18.6 kg to 18.9 kg, P = 0.16, respectively), those in the dulaglutide group significantly decreased (from 21.9 kg to 18.9 kg, P = 0.037 and 21.0 kg to 20.2 kg, P = 0.011, respectively). CONCLUSIONS Six months of dulaglutide treatment significantly reduced not only FM but also SMM, although changes in GA and insulin doses were comparable with those in the teneligliptin group. Dulaglutide may have the effect of promoting sarcopenia; therefore, it may be carefully used in T2DM patients on HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0264 · Cited by 778
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766
Nauck, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12591 · Cited by 429
Jendle, J., Nauck, M. A., Matthews, D. R., Frid, A., Hermansen, K., Düring, M., Zdravkovic, M., Strauss, B. J., Garber, A. J., & Groups, O. B. O. T. L. A. L. S. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01158.x · Cited by 312
Chai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., & Liu, Z. (2012) · Diabetes · doi:10.2337/db11-1073 · Cited by 194
Perna, S., Guido, D., Bologna, C., Solerte, S. B., Guerriero, F., Isu, A., & Rondanelli, M. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0525-y · Cited by 125
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044284 · Cited by 80
Research works printed but not linked: 19
- Masakane, 2015, An overview of regular dialysis treatment in Japan (as of 31 December 2013), Ther Apher Dial, 19, 540, 10.1111/1744-9987.12378 · DOI · Paper page
- United States Renal Data System, 2016, US renal data system 2015 annual data report: epidemiology of kidney disease in the United States, Am J Kidney Dis, 67, S1
- Freedman, 2011, Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients, Clin J Am Soc Nephrol, 6, 1635, 10.2215/CJN.11491210 · DOI · Paper page
- Isshiki, 2014, Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival, Ther Apher Dial, 18, 434, 10.1111/1744-9987.12123 · DOI
- Yajima, 2016, Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis, J Diabetes Complications, 30, 786, 10.1016/j.jdiacomp.2016.02.021 · DOI
- Yajima, 2016, Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring, Diabetes Res Clin Pract, 122, 78, 10.1016/j.diabres.2016.10.016 · DOI
- Yajima, 2018, Improved glycemic control with once-weekly dulaglutide in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring, J Diabetes Complications, 32, 310, 10.1016/j.jdiacomp.2017.12.005 · DOI
- Hong, 2016, Effects of short-term exenatide treatment on regional fat distribution, glycated hemoglobin levels, and aortic pulse wave velocity of obese type 2 diabetes mellitus patients, Endocrinol Metab, 31, 80, 10.3803/EnM.2016.31.1.80 · DOI · Paper page
- Rondanelli, 2016, Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus, Patient Prefer Adherence, 10, 407
- Noori, 2010, Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease, Semin Dial, 23, 178, 10.1111/j.1525-139X.2010.00705.x · DOI
- Kalantar-Zadeh, 2006, Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients, Am J Clin Nutr, 83, 202, 10.1093/ajcn/83.2.202 · DOI · Paper page
- Kaysen, 2005, Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy, Am J Clin Nutr, 82, 988, 10.1093/ajcn/82.5.988 · DOI
- Yamada, 2008, Simplified nutritional screening tools for patients on maintenance hemodialysis, Am J Clin Nutr, 87, 106, 10.1093/ajcn/87.1.106 · DOI · Paper page
- Leenders, 2013, Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging, J Am Med Dir Assoc, 14, 585, 10.1016/j.jamda.2013.02.006 · DOI · Paper page
- Kalyani, 2010, Association of diabetes, comorbidities, and A1C with functional disability in older adults, Diabetes Care, 33, 1055, 10.2337/dc09-1597 · DOI · Paper page
- Umegaki, 2016, Sarcopenia and frailty in older patients with diabetes mellitus, Geriatr Gerontol Int, 16, 293, 10.1111/ggi.12688 · DOI · Paper page
- American Diabetes Association, 2017, Obesity management for the treatment of type 2 diabetes, Diabetes Care, 40, S57, 10.2337/dc17-S010 · DOI
- Kato, 2015, Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes, Diabetes Res Clin Pract, 109, 199, 10.1016/j.diabres.2015.04.008 · DOI
- Acitores, 2004, Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle, J Endocrinol, 180, 389, 10.1677/joe.0.1800389 · DOI · Paper page
Cited by
Marx, N., Husain, M., Lehrke, M., Verma, S., & Sattar, N. (2022) · Circulation · doi:10.1161/circulationaha.122.059595 · Cited by 483
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
Wilbon, S. S., & Kolonin, M. G. (2023) · Cells · doi:10.3390/cells13010065 · Cited by 101
Ren, Q., Chen, S., Chen, X., Niu, S., Yue, L., Pan, X., Li, Z., & Chen, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s381546 · Cited by 91
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Hong, C.-T., Chen, J.-H., & Hu, C.-J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01090-x · Cited by 78
Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia
Memel, Z., Gold, S. L., Pearlman, M., Muratore, A., & Martindale, R. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00649-w · Cited by 63
Metadata
- Authors
- Yajima, T., Yajima, K., Takahashi, H., & Yasuda, K.
- Venue
- Journal of Diabetes and its Complications
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 32
- Issue
- 8
- Pages
- 759-763
- ISSN
- 0891-6632 (ISSN-L)
- 1056-8727
- OpenAlex
- W2805267532
- Cited by
- 45
- References
- 7
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis. https://app.cochat.ai/papers/10.1016/j.jdiacomp.2018.05.018
- The paper
- Yajima, T., Yajima, K., Takahashi, H., & Yasuda, K. (2018). The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis. Journal of Diabetes and its Complications. https://doi.org/10.1016/j.jdiacomp.2018.05.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.